Che-jui Lee
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies.
Journal: Translational oncology
Published: September 15, 2025
Urokinase Plasminogen Activator Receptor-Associated Protein (uPARAP) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors (GIST).
Journal: International journal of cancer
Published: May 12, 2025
Potentially actionable targets in synovial sarcoma: A tissue microarray study.
Journal: Translational oncology
Published: May 03, 2024
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Journal: British journal of cancer
Published: June 03, 2022
Correction to: Machine learning for rhabdomyosarcoma histopathology.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 16, 2022
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Journal: International journal of molecular sciences
Published: May 02, 2022
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.
Journal: Biomedicines
Published: February 22, 2022
Machine learning for rhabdomyosarcoma histopathology.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 03, 2021
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.
Journal: Cancers
Published: October 06, 2021
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 02, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2021
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center.
Journal: Oncology research and treatment
Published: March 04, 2021
Last Updated: 09/26/2026